Pocket hematoma after pacemaker or defibrillator surgery: Direct oral anticoagulants versus vitamin K antagonists.
de Heide J, van der Graaf M, Holl MJ, Bhagwandien RE, Theuns DAMJ, de Wit A, Zijlstra F, Szili-Torok T, Lenzen MJ, Yap SC.
Int J Cardiol Heart Vasc. 2022 Mar 16;39:101005. doi: 10.1016/j.ijcha.2022.101005. eCollection 2022 Apr.
PMID:35310376
An atypical pacemaker pocket hematoma containing chyliform fluid.
Maffè S, Paffoni P, Bergamasco L, Arrondini M, Dellavesa P.
Indian Pacing Electrophysiol J. 2022 May-Jun;22(3):161-164. doi: 10.1016/j.ipej.2022.03.002. Epub 2022 Apr 1.
PMID:35378279
Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2).
Birnie DH, Healey JS, Wells GA, Ayala-Paredes F, Coutu B, Sumner GL, Becker G, Verma A, Philippon F, Kalfon E, Eikelboom J, Sandhu RK, Nery PB, Lellouche N, Connolly SJ, Sapp J, Essebag V.
Eur Heart J. 2018 Nov 21;39(44):3973-3979. doi: 10.1093/eurheartj/ehy413.
PMID:30462279
Sub-pocket small-hole drainage for pocket hematoma after cardiac device implantation.
Wei Y, Cai L, Wu X, Zhou G, Lu X, Peng S, Ding Y, Xu J, Chen S, Ouyang P, Liu S.
Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy.